Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Citizen Petitions May Be Enforcement Target If FTC Finds Repetitive Pattern

Executive Summary

The Federal Trade Commission wants to clarify through future case law that repeated petitioning of the government could be subject to antitrust enforcement

You may also be interested in...

FDA Will Refer Potentially Anti-Competitive Citizen Petitions To FTC

Questionable citizen petitions will be referred to the Federal Trade Commission, FDA says in a report made to House and Senate appropriations committees

“Orange Book” Listings Are Not Immune From Antitrust Scrutiny, FTC Says

"Orange Book" patent listings should not be afforded the same antitrust exemption given to "petitioning," the Federal Trade Commission maintains in an amicus curiae brief filed as part of a state attorneys general action against Bristol-Myers Squibb

Pink Sheet Podcast: COVID-19 Stresses Manufacturing, Vaccine Placebo Controls, Thorny FDA Precedents

Pink Sheet reporters and editor discuss the pandemic’s effects on non-coronavirus-related product manufacturing, US FDA efforts to ensure vaccine sponsors maintain placebo controls once a product is available, and precedents that burden the agency.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts